The Valence Group Announces Successfully Advising DSM on its Sale of Citrique Belge to Adcuram

The Valence Group announces that it has successfully advised Royal DSM N.V., on the sale of Citrique Belge to Adcuram. The intended sale is expected to close in Q4 2010, subject to customary approvals and notifications.

Both parties have agreed not to disclose financial details at this time. Citrique Belge reported over a‚¬100 million in sales in 2009.

Kirk McIntosh, Partner, said: We are very excited to be working with DSM and proud to have played a role in their strategic realignment. Our successful relationship is further evidence that The Valence Group remains the premier advisor to the global chemicals industry

About The Valence Group

The Valence Group is a specialist M&A boutique offering advisory services exclusively to companies and investors in the chemicals, materials and related sectors. The firm has developed broad and deep transactional expertise: sell-side, buy-side, joint venture, private companies, public offers, corporate carve-outs, LBOs and management buy-outs. The founders and senior members of The Valence Group have worked together for between 10 and 15 years and collectively have more than 130 years of transactional experience gained both at major investment banks and within chemical companies. The firm’s offices are located in London, New York and Shanghai.